Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06018480 · ClinicalTrials.gov registry record · NA
The Effect of NADPH Oxidase and Creatine Supplementation on Microvascular Blood Flow Regulation
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT06018480: Completed NA study, sponsored by Florida State University.
NCT06018480 is a NA study that has completed, run by Florida State University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06018480, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This research study seeks to determine the effects of an enzyme in the human body called NADPH oxidase (NOX) on blood flow. In addition, the study will investigate the benefits of creatine monohydrate, a common sports performance supplement, on blood food and vessel function. Participants will undergo two study arms, one in which they consume a high carbohydrate meal pre- and post-creatine monohydrate supplementation and one in which they will consume a high carbohydrate meal pre- and post-placebo supplementation. Blood flow and endothelial function will be assessed before and for 4 hours following the consumption of a high-carbohydrate meal pre and post-supplementation (creatine monohydrate and placebo).
Primary Outcome
Reactive oxygen species measured with microdialysis, reported as hydrogen peroxide (H2O2) concentrations.
Interventions
- OTHER Creatine Monohydrate
- OTHER Maltodextrin (Placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2024-01-30 |
| Phase | NA |
What the finished NCT06018480 record still lists
NCT06018480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Creatine Monohydrate is the first listed.
NCT06018480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06018480 about?
NCT06018480 is a clinical study titled "The Effect of NADPH Oxidase and Creatine Supplementation on Microvascular Blood Flow Regulation". This research study seeks to determine the effects of an enzyme in the human body called NADPH oxidase (NOX) on blood flow. In addition, the study will investigate the benefits of creatine monohydrate, a common sports performance supplement, on blood food and vessel function. Participants will under...
What is the current status of trial NCT06018480?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2023-08-29. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT06018480?
The interventions under investigation include: Creatine Monohydrate (OTHER), Maltodextrin (Placebo) (OTHER).
Who is sponsoring clinical trial NCT06018480?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06018480's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI